Natixis Advisors, L.P. Integra Lifesciences Holdings Corp Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$34.21 - $44.59 $360,470 - $469,844	10,537 New	10,537 $458,000
Q1 2023 May 11, 2023	BUY	$52.61 - $60.49 $323,078 - $371,469	6,141 Added 23.24%	32,570 $1.87 Million
Q4 2022 Jan 27, 2023	BUY	$42.17 - $58.6 $314,166 - $436,570	7,450 Added 39.25%	26,429 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$42.28 - $57.17 $106,291 - $143,725	2,514 Added 15.27%	18,979 $804,000
Q2 2022 Aug 12, 2022	SELL	$53.86 - $66.52 $65,870 - $81,353	-1,223 Reduced 6.91%	16,465 $890,000
Q1 2022 May 12, 2022	BUY	$62.86 - $69.24 $8,486 - $9,347	135 Added 0.77%	17,688 $1.14 Million
Q4 2021 Feb 08, 2022	BUY	$62.47 - $73.25 $102,388 - $120,056	1,639 Added 10.3%	17,553 $1.18 Million
Q3 2021 Nov 15, 2021	BUY	$64.97 - $76.19 $85,370 - $100,113	1,314 Added 9.0%	15,914 $1.09 Million
Q2 2021 Aug 12, 2021	BUY	$66.79 - $76.63 $6,345 - $7,279	95 Added 0.65%	14,600 $996,000
Q1 2021 May 05, 2021	BUY	$62.63 - $71.15 $46,721 - $53,077	746 Added 5.42%	14,505 $1 Million
Q4 2020 Feb 12, 2021	BUY	$43.31 - $66.55 $125,252 - $192,462	2,892 Added 26.61%	13,759 $893,000
Q3 2020 Nov 12, 2020	SELL	$43.33 - $51.72 $3.07 Million - $3.67 Million	-70,898 Reduced 86.71%	10,867 $513,000
Q2 2020 Aug 11, 2020	SELL	$41.42 - $55.57 $509,424 - $683,455	-12,299 Reduced 13.08%	81,765 $3.84 Million
Q1 2020 Apr 27, 2020	BUY	$36.67 - $61.04 $825,735 - $1.37 Million	22,518 Added 31.47%	94,064 $4.2 Million
Q4 2019 Feb 10, 2020	BUY	$55.73 - $62.49 $121,212 - $135,915	2,175 Added 3.14%	71,546 $4.17 Million
Q3 2019 Nov 12, 2019	BUY	$53.29 - $64.59 $115,212 - $139,643	2,162 Added 3.22%	69,371 $4.17 Million
Q2 2019 Aug 12, 2019	SELL	$46.45 - $55.85 $840,466 - $1.01 Million	-18,094 Reduced 21.21%	67,209 $3.75 Million
Q1 2019 May 15, 2019	BUY	$42.97 - $57.33 $726,493 - $969,278	16,907 Added 24.72%	85,303 $4.75 Million
Q4 2018 Feb 13, 2019	BUY	$42.62 - $64.51 $1.46 Million - $2.21 Million	34,245 Added 100.28%	68,396 $3.08 Million
Q3 2018 Nov 13, 2018	BUY	$57.63 - $65.87 $138,312 - $158,088	2,400 Added 7.56%	34,151 $2.25 Million
Q2 2018 Aug 14, 2018	SELL	$54.05 - $67.23 $884,149 - $1.1 Million	-16,358 Reduced 34.0%	31,751 $0
Q1 2018 May 10, 2018	SELL	$46.55 - $57.38 $50,413 - $62,142	-1,083 Reduced 2.2%	48,109 $2.66 Million
Q4 2017 Feb 14, 2018	SELL	$46.22 - $51.77 $1.23 Million - $1.38 Million	-26,667 Reduced 35.15%	49,192 $2.35 Million
Q3 2017 Nov 14, 2017	BUY	$47.8 - $53.63 $3.63 Million - $4.07 Million	75,859	75,859 $3.83 Million

Others Institutions Holding IART

# of Institutions

241

Shares Held

75.3M

Call Options Held

585K

Put Options Held

21.3K

Black Rock Inc. New York, NY

11.3M
Shares

$249 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.74M
Shares

$172 Million
0.0% of portfolio
Morgan Stanley New York, NY

5.26M
Shares

$116 Million
0.01% of portfolio
Eaton Vance Management Boston, MA

4.22M
Shares

$93.4 Million
0.26% of portfolio
Fuller & Thaler Asset Management, Inc. San Mateo, CA

3.97M
Shares

$87.9 Million
0.29% of portfolio

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $1.85B
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account